ClinicalTrials.gg
RecruitingNCT07332949SEXODIAUpdated Feb 4, 2026

Impact of Dialysis on Sexuality.

An observational study in Chronic Kidney Disease Requiring Chronic Dialysis, sponsored by CMC Ambroise Paré. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-04.

Sponsored by CMC Ambroise Paré · Observational

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Sexuality is an essential dimension of quality of life and is frequently impaired in patients with end-stage chronic kidney disease undergoing hemodialysis. Sexual dysfunctions-including erectile dysfunction, reduced sexual desire, and difficulties with arousal or orgasm-are highly prevalent in this population. These disorders have multifactorial origins, involving hormonal disturbances, comorbidities, treatment-related side effects, chronic fatigue, and the psychological and relational impact of long-term illness.

Despite their frequency, sexual health issues are rarely addressed in routine dialysis care. This is largely due to time constraints during consultations, insufficient training of healthcare professionals, and persistent social and cultural taboos. In addition, the existing scientific literature remains limited, often outdated, and predominantly focused on male patients. Data concerning women, sexual diversity, body image, and couple-related aspects are scarce. Standard kidney disease-specific quality-of-life instruments, such as the KDQOL questionnaire, provide only a minimal assessment of sexuality, with a single item related to sexual desire.

The aim of this study is to provide a contemporary and comprehensive assessment of the impact of dialysis on sexual quality of life. By documenting sexual function and sexual complaints in patients undergoing dialysis, this study seeks to improve understanding of patients' experiences and to facilitate communication between patients and healthcare professionals. Ultimately, the findings are intended to support better integration of sexual health into routine nephrology care and to contribute to improved clinical practices in the field of sexual health.

This study is designed as a cross-sectional survey conducted among patients undergoing dialysis at the Groupe Hospitalier Privé Ambroise Paré-Hartmann in the Paris area. Eligible patients are informed about the study during a dialysis session by a healthcare professional (dialysis nurse, nephrologist, or physiotherapist specialized in sexology). Participants complete a self-administered questionnaire during their dialysis session, including the Male Sexual Health Questionnaire (MSHQ) for men and the Female Sexual Function Index (FSFI) for women. Additional questions addressing medical history and body image perception are included. The estimated completion time for the questionnaire is approximately 20 minutes.

02

Conditions studied

  • Chronic Kidney Disease Requiring Chronic Dialysis

Browse trials for

Keywords

  • Hemodialysis
  • Peritoneal dialysis
  • Sexuality
03

In context

Sexuality

130 studies on the registry are indexed under Sexuality; 26 are open to participants now.

This study's planned enrollment of 100 is close to the median of 100 across 47 observational studies indexed under Sexuality.

Browse Sexuality studies →

Lead sponsor

CMC Ambroise Paré is the lead sponsor of 47 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adults treated with chronic dialysis (hemodialysis or peritoneal dialysis).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient > 18 years,
  • Treated with chronic dialysis (hemodialysis or peritoneal dialysis) for at least 6 months.

Exclusion criteria

Exclusion Criteria:

  • Major cognitive or psychiatric disorders that make understanding or completing the questionnaire difficult.
  • General health condition not allowing participation without significant discomfort or excessive fatigue.
  • Opposition by the patient.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adults treated with chronic dialysis

    Other: Questionnaire on sexuality

Interventions

  • OtherQuestionnaire on sexuality

    The patients will receive the following questionnaires to complete during the dialysis session: * MSHQ (Male Sexual Health Questionnaire) for men * FSFI (Female Sexual Function Index) for women Additional questions addressing medical history and body image perception are included.

06

What researchers measure

Primary outcomes

  1. Sexual quality of life

    The MSHQ questionnaire for men consists of 25 questions, minimum score: 25, maximum score: 125. A higher score on this scale indicates better sexual function.

    Time frame: At baseline, during a dialysis session

  2. Sexual quality of life

    The FSFI questionnaire for women consists of 19 questions, minimum score: 2, maximum score: 36. A higher score on this scale indicates better sexual function.

    Time frame: At baseline, during a dialysis session

Secondary outcomes

  1. Body perception

    Questionnaire adapted from the Body Image Scale consisting of 4 questions, minimum score: 0, maximum score: 12. A higher score indicates a poorer body image.

    Time frame: At baseline, during a dialysis session

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07332949
Lead sponsor
CMC Ambroise Paré
Responsible party
Sponsor
First posted
Jan 12, 2026
Start date
Jan 30, 2026
Primary completion
Jan 30, 2027 (estimated)
Completion
Jan 30, 2027 (estimated)
Last update
Feb 4, 2026

Study contacts

Nicolas Benichou, MD
Contact
nicolas.benichou@clinique-a-pare.fr
0146415079 ext. +33

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion